206 related articles for article (PubMed ID: 18503482)
1. Clinical correlation between dyslipidemia and pediatric chronic allograft nephropathy.
Valavi E; Otukesh H; Fereshtehnejad SM; Sharifian M
Pediatr Transplant; 2008 Nov; 12(7):748-54. PubMed ID: 18503482
[TBL] [Abstract][Full Text] [Related]
2. A long-term study on hyperlipidemia in stable renal transplant recipients.
Tse KC; Lam MF; Yip PS; Li FK; Lai KN; Chan TM
Clin Transplant; 2004 Jun; 18(3):274-80. PubMed ID: 15142048
[TBL] [Abstract][Full Text] [Related]
3. Prospective monitoring of lipid profiles in children receiving pravastatin preemptively after renal transplantation.
Butani L
Pediatr Transplant; 2005 Dec; 9(6):746-53. PubMed ID: 16269046
[TBL] [Abstract][Full Text] [Related]
4. Correlation of C0 and C2 levels with lipid profiles in adolescent renal transplant recipients in the early and late posttransplant periods.
Soylu A; Kavukçu S; Türkmen MA; Kasap B; Soylu A; Bora S; Gülay H
Transplant Proc; 2006 Jun; 38(5):1286-9. PubMed ID: 16797283
[TBL] [Abstract][Full Text] [Related]
5. [Dyslipidemia and the risk of kidney disease].
Ligabue G; Cavazzini F; Albertazzi A
G Ital Nefrol; 2007; 24 Suppl 38():8-12. PubMed ID: 17922441
[TBL] [Abstract][Full Text] [Related]
6. A prudent algorithm for hyperlipoproteinemia in renal transplant recipients.
Nart A; Uslu A; Bozkaya G; Aykas A; Dogan M; Karaca B
Transplant Proc; 2009 Mar; 41(2):751-5. PubMed ID: 19328972
[TBL] [Abstract][Full Text] [Related]
7. Pediatric kidney transplantation is safe and available for patients with urological anomalies as well as those with primary renal diseases.
Morita K; Iwami D; Hotta K; Shimoda N; Miura M; Watarai Y; Hoshii S; Obikane K; Nakashima T; Sasaki S; Nonomura K
Pediatr Transplant; 2009 Mar; 13(2):200-5. PubMed ID: 18662371
[TBL] [Abstract][Full Text] [Related]
8. Determinants of renal function in pediatric heart transplant recipients: long-term follow-up study.
Sachdeva R; Blaszak RT; Ainley KA; Parker JG; Morrow WR; Frazier EA
J Heart Lung Transplant; 2007 Feb; 26(2):108-13. PubMed ID: 17258142
[TBL] [Abstract][Full Text] [Related]
9. Lipid disturbances before and after renal transplant.
Razeghi E; Shafipour M; Ashraf H; Pourmand G
Exp Clin Transplant; 2011 Aug; 9(4):230-5. PubMed ID: 21819366
[TBL] [Abstract][Full Text] [Related]
10. Urinary tract infections in pediatric renal transplant recipients--a two center risk factors study.
Feber J; Spatenka J; Seeman T; Matousovic K; Zeman L; Dusek J; Morávek J; Janda J; Barrowman NJ; Guerra L; Leonard M
Pediatr Transplant; 2009 Nov; 13(7):881-6. PubMed ID: 19170928
[TBL] [Abstract][Full Text] [Related]
11. Chronic renal disease in renal transplant patients: management of cardiovascular risk factors.
Fernández-Fresnedo G; Gómez-Alamillo C; Ruiz JC; de Francisco AL; Arias M
Transplant Proc; 2009 Jun; 41(5):1637-8. PubMed ID: 19545697
[TBL] [Abstract][Full Text] [Related]
12. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
13. Ezetimibe in the treatment of uncontrolled hyperlipidemia in kidney transplant patients.
Rodríguez-Ferrero ML; Anaya F
Transplant Proc; 2008 Dec; 40(10):3492-5. PubMed ID: 19100421
[TBL] [Abstract][Full Text] [Related]
14. Treatment with ezetimibe in kidney transplant recipients with uncontrolled dyslipidemia.
López V; Gutiérrez C; Gutiérrez E; Sola E; Cabello M; Burgos D; González Molina M
Transplant Proc; 2008 Nov; 40(9):2925-6. PubMed ID: 19010149
[TBL] [Abstract][Full Text] [Related]
15. Chronic kidney disease in children following lung and heart-lung transplantation.
Benden C; Kansra S; Ridout DA; Shaw NL; Aurora P; Elliott MJ; Marks SD
Pediatr Transplant; 2009 Feb; 13(1):104-10. PubMed ID: 19087230
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of kidney transplantation in children with nephronophthisis: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry.
Hamiwka LA; Midgley JP; Wade AW; Martz KL; Grisaru S
Pediatr Transplant; 2008 Dec; 12(8):878-82. PubMed ID: 19000067
[TBL] [Abstract][Full Text] [Related]
17. Improved long-term graft function in pediatric transplant renal recipients with chronic allograft nephropathy.
Kerecuk L; Horsfield C; Taylor J
Pediatr Transplant; 2009 May; 13(3):324-31. PubMed ID: 18537899
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the vaccination status in pediatric renal transplant recipients.
Chaves TS; Pereira LM; De Santos SS; David-Neto E; Lopes MH
Pediatr Transplant; 2008 Jun; 12(4):432-5. PubMed ID: 18466429
[TBL] [Abstract][Full Text] [Related]
19. Derangement of lipid metabolism and its management in renal transplant patients.
Keane WF
Miner Electrolyte Metab; 1997; 23(3-6):166-9. PubMed ID: 9387109
[TBL] [Abstract][Full Text] [Related]
20. Estimated one-yr glomerular filtration rate is an excellent predictor of long-term graft survival in pediatric first kidney transplants.
Muscheites J; Wigger M; Drueckler E; Klaassen I; John U; Wygoda S; Fischer DC; Kundt G; Misselwitz J; Müller-Wiefel DE; Haffner D
Pediatr Transplant; 2009 May; 13(3):365-70. PubMed ID: 18537896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
